BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37403109)

  • 1. Cytoreductive surgery offers prognostic benefits in metastatic gastrointestinal stromal tumors with generalized progression following imatinib therapy: a single institute retrospective study.
    Liu DN; Jia WW; Wang HY; Wu JH; Li CP; Hao CY
    BMC Surg; 2023 Jul; 23(1):189. PubMed ID: 37403109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Surgery in Metastatic Gastrointestinal Stromal Tumors.
    Keung EZ; Fairweather M; Raut CP
    Curr Treat Options Oncol; 2016 Feb; 17(2):8. PubMed ID: 26820287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoreductive Surgery for Metastatic Gastrointestinal Stromal Tumors Treated With Tyrosine Kinase Inhibitors: A 2-institutional Analysis.
    Fairweather M; Balachandran VP; Li GZ; Bertagnolli MM; Antonescu C; Tap W; Singer S; DeMatteo RP; Raut CP
    Ann Surg; 2018 Aug; 268(2):296-302. PubMed ID: 28448384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical Management of Metastatic Gastrointestinal Stromal Tumors.
    Yonkus JA; Alva-Ruiz R; Grotz TE
    Curr Treat Options Oncol; 2021 Mar; 22(5):37. PubMed ID: 33743084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of surgical treatment for recurrent and metastatic gastrointestinal stromal tumors].
    Zhang XH; He YL
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Sep; 23(9):840-844. PubMed ID: 32927506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility and Timing of Cytoreduction Surgery in Advanced (Metastatic or Recurrent) Gastrointestinal Stromal Tumors During the Era of Imatinib.
    Chang SC; Liao CH; Wang SY; Tsai CY; Chiang KC; Cheng CT; Yeh TS; Chen YY; Ma MC; Liu CT; Yeh CN
    Medicine (Baltimore); 2015 Jun; 94(24):e1014. PubMed ID: 26091448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical management of patients with progressing metastatic gastrointestinal stromal tumors receiving sunitinib treatment: A prospective cohort study.
    Yeh CN; Wang SY; Tsai CY; Chen YY; Liu CT; Chiang KC; Chen TW; Liu YY; Yeh TS
    Int J Surg; 2017 Mar; 39():30-36. PubMed ID: 28110026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Long-Term Adjuvant Therapy With Imatinib Mesylate After Extensive Surgical Treatment for Ruptured Gastrointestinal Stromal Tumors of the Small Intestine With Peritoneal Metastases: A Case Report.
    Kimura T; Togawa T; Onishi K; Iida A; Sato Y; Goi T
    J Investig Med High Impact Case Rep; 2020; 8():2324709620970736. PubMed ID: 33228387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of surgery in patients with focally progressive gastrointestinal stromal tumors resistant to imatinib.
    Gao X; Xue A; Fang Y; Shu P; Ling J; Qin J; Hou Y; Shen K; Sun Y; Qin X
    Sci Rep; 2016 Mar; 6():22840. PubMed ID: 26946961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal stromal tumors (GIST) related emergencies.
    Sorour MA; Kassem MI; Ghazal Ael-H; El-Riwini MT; Abu Nasr A
    Int J Surg; 2014; 12(4):269-80. PubMed ID: 24530605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term survival outcome with tyrosine kinase inhibitors and surgical intervention in patients with metastatic or recurrent gastrointestinal stromal tumors: A 14-year, single-center experience.
    Kim JH; Ryu MH; Yoo C; Chae H; Na H; Beck M; Kim BS; Yoo MW; Yook JH; Kim BS; Kim KH; Kim CW; Kang YK
    Cancer Med; 2019 Mar; 8(3):1034-1043. PubMed ID: 30693663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of Surgery and Outcome in Localized Gastrointestinal Stromal Tumors Treated Within an International Intergroup Randomized Clinical Trial of Adjuvant Imatinib.
    Gronchi A; Bonvalot S; Poveda Velasco A; Kotasek D; Rutkowski P; Hohenberger P; Fumagalli E; Judson IR; Italiano A; Gelderblom HJ; van Coevorden F; Penel N; Kopp HG; Duffaud F; Goldstein D; Broto JM; Wardelmann E; Marréaud S; Smithers M; Le Cesne A; Zaffaroni F; Litière S; Blay JY; Casali PG
    JAMA Surg; 2020 Jun; 155(6):e200397. PubMed ID: 32236507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Factors After Neoadjuvant Imatinib for Newly Diagnosed Primary Gastrointestinal Stromal Tumor.
    Cavnar MJ; Seier K; Gönen M; Curtin C; Balachandran VP; Tap WD; Antonescu CR; Singer S; DeMatteo RP
    J Gastrointest Surg; 2021 Jul; 25(7):1828-1836. PubMed ID: 33169327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST).
    Tang S; Yin Y; Shen C; Chen J; Yin X; Zhang B; Yao Y; Yang J; Chen Z
    World J Surg Oncol; 2017 Apr; 15(1):79. PubMed ID: 28399894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of morbidity following cytoreductive surgery for metastatic gastrointestinal stromal tumour in patients on tyrosine kinase inhibitor therapy.
    Fairweather M; Cavnar MJ; Li GZ; Bertagnolli MM; DeMatteo RP; Raut CP
    Br J Surg; 2018 May; 105(6):743-750. PubMed ID: 29579329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal stromal tumors: diagnosis and treatment.
    Acín-Gándara D; Pereira-Pérez F; Castaño-Pascual A; Durán-Poveda M; Antequera-Pérez A; Miliani-Molina C
    Cir Cir; 2012; 80(1):44-51. PubMed ID: 22472152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of surgical intervention for imatinib-resistant gastrointestinal stromal tumors in the era of multiple tyrosine kinase inhibitors.
    Wada N; Takahashi T; Kurokawa Y; Nakajima K; Nishida T; Koh M; Akamaru Y; Motoori M; Kimura Y; Tanaka K; Miyazaki Y; Makino T; Yamasaki M; Eguchi H; Doki Y
    Surg Today; 2021 Sep; 51(9):1506-1512. PubMed ID: 33570662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal stromal tumor (GIST) with liver metastases: An 18-year experience from the GIST cooperation group in North China.
    Shi YN; Li Y; Wang LP; Wang ZH; Liang XB; Liang H; Zhang L; Li B; Fan LQ; Zhao Q; Ma ZX; Zhao XF; Zhang ZD; Liu Y; Tan BB; Wang D; Wang LL; Hao YJ; Jia N
    Medicine (Baltimore); 2017 Nov; 96(46):e8240. PubMed ID: 29145240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoreductive surgery for metastatic gastrointestinal stromal tumors followed by sunitinib compared to followed by imatinib-a multi-center cohort study.
    Zhang X; Zhou Y; Wu X; Nie M; Zhang B; Zhou Y; Sun L; Liu Z; Liu X; Kou Y; Wang Y; Zhang Y; Hao C; Shen L; Li J
    Eur J Surg Oncol; 2019 Mar; 45(3):318-323. PubMed ID: 30145000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing prognostic factors of long-term survival after surgery for colorectal gastrointestinal stromal tumours.
    Yang S; Maspero M; Holubar SD; Hull TL; Lightner AL; Valente MA; Gorgun E; Kalady MF; Steele SR; Liska D
    Colorectal Dis; 2023 Dec; 25(12):2325-2334. PubMed ID: 37876119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.